Welcome to the real world Matthew Gordon examines the differences between observational studies and phase III clinical trials(more)
Drug regulation: still room for improvement The Medicines Act is 40 years old this year, but regulations and regulators have to change to keep up with rapid changes in medicines and society, says Les Rose.(more)
The devil is in the detail Friday , June 10, 2005
Andrew Platten looks at what impact the Department of Health's latest guidance on practice based commissioning will have on pharma salesforces and products. ...(more)
Does practice make perfect targeting? Friday , June 03, 2005
Dr Paul Tunnah looks at how to carry out effective primary care promotion through customer analysis and considers whether a doctor or practice based approach is the answer. ...(more)
Is your R&D team an outside bet? Thursday , June 02, 2005
Adopting a more scientific approach to commercial decision-making could put your new product development capability on the winning track, suggests Alex Blyth....(more)
Chipping away at the counterfeit trade Wednesday, June 01, 2005
Jonathan Akehurst looks at the burgeoning counterfeit medicines business and finds out what UK pharma has in common with Manchester United and the US Army....(more)
